The main prognostic factors for BC are tumor size, axillary nodal status, tumor pathology, tumor grade, peritumoral lymphatic vessel and vascular invasion, hormonal receptor status, proliferation markers, age, and ethnicity, among others [9,10]. This evidence concerns the gene NR4A1 and breast cancer.